NovaBridge Biosciences American Depositary Shares
NBP
28 hedge funds and large institutions have $10.1M invested in NovaBridge Biosciences American Depositary Shares in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 7 closing their positions.
0% more funds holding
Funds holding: 28 → 28 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
1.23% less ownership
Funds ownership: 7.63% → 6.4% (-1.2%)
42% less capital invested
Capital invested by funds: $17.6M → $10.1M (-$7.48M)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $12K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$3.91M |
| 2 |
SG Americas Securities
New York
|
+$530K |
| 3 |
CF
Cantor Fitzgerald
New York
|
+$156K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$122K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$115K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CP
Caligan Partners
New York
|
-$4.34M |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$1.76M |
| 3 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$1.03M |
| 4 |
Temasek Holdings
Singapore
|
-$703K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$108K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VWM
26
Vermillion Wealth Management
Rosemount,
Minnesota
| $170 | +$223 | +200 | New |
|
27
Citigroup
New York
| $43 | – | – | – |
|
|
CP
28
Caligan Partners
New York
| – | -$4.34M | -3,499,330 | Closed |
|
|
BFM
29
Boothbay Fund Management
New York
| – | -$1.76M | -1,419,080 | Closed |
|
|
30
Temasek Holdings
Singapore
| – | -$703K | -566,650 | Closed |
|
|
XT
31
XTX Topco
George Town,
Cayman Islands
| – | -$53.4K | -43,039 | Closed |
|
32
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$16.6K | -13,351 | Closed |
|
|
TRCT
33
Tower Research Capital (TRC)
New York
| – | -$4.98K | -4,015 | Closed |
|
34
BlackRock
New York
| – | -$1.78K | -1,438 | Closed |
|
35
Simplex Trading
Chicago,
Illinois
| – | +$442 | +397 | +95% |
|
NBP Hedge Fund Activity: Q4 2024 in Review
28 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q4 2024, worth a combined $10.1M — down 42% from $17.6M a quarter earlier.
Fund positioning in NBP was balanced in Q4 2024: 7 funds opened new positions, 7 closed out, 3 added to existing stakes and 6 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $3.91M. The largest seller was Caligan Partners, exiting entirely with an estimated $4.34M sold.
- 28 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $10.1M of NovaBridge Biosciences American Depositary Shares stock for Q4 2024, down 42% quarter-over-quarter.
- 7 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q4 2024 and 7 closed out, a net change of 0 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q4 2024 was Morgan Stanley, an estimated $3.91M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q4 2024 was Caligan Partners, an estimated $4.34M sold.
Based on aggregated 13F filings for Q4 2024.